Amplia Therapeutics Limited (INNMF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -1.82 Million AUD | 74.23% |
| 2023 | -6.98 Million AUD | 44.19% |
| 2022 | -12.5 Million AUD | -576.85% |
| 2021 | -1.84 Million AUD | -66.79% |
| 2020 | -1.1 Million AUD | 9.95% |
| 2019 | -1.23 Million AUD | 44.54% |
| 2018 | -2.21 Million AUD | 61.44% |
| 2017 | -5.75 Million AUD | -80.29% |
| 2016 | -3.19 Million AUD | 21.97% |
| 2015 | -4.08 Million AUD | 48.51% |
| 2014 | -7.94 Million AUD | 5.0% |
| 2013 | -8.35 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -3.49 Million AUD | 49.94% |
| 2024 Q2 | -3.41 Million AUD | 2.22% |
| 2024 Q4 | -1.82 Million AUD | 0.0% |
| 2024 FY | -1.82 Million AUD | 73.88% |
| 2023 Q3 | -7.05 Million AUD | 24.75% |
| 2023 Q1 | -9.44 Million AUD | 24.5% |
| 2023 FY | -6.98 Million AUD | 44.19% |
| 2023 Q2 | -9.37 Million AUD | 0.71% |
| 2023 Q4 | -6.98 Million AUD | 1.06% |
| 2022 Q4 | -12.5 Million AUD | 0.0% |
| 2022 Q2 | -3.17 Million AUD | 0.0% |
| 2022 FY | -12.5 Million AUD | -576.85% |
| 2021 Q4 | -1.84 Million AUD | 0.0% |
| 2021 FY | -1.84 Million AUD | -66.79% |
| 2021 Q2 | -3.76 Million AUD | 0.0% |
| 2020 Q2 | -1.2 Million AUD | 0.0% |
| 2020 Q4 | -1.1 Million AUD | 0.0% |
| 2020 FY | -1.1 Million AUD | 9.95% |
| 2019 FY | -1.23 Million AUD | 44.54% |
| 2019 Q4 | -1.23 Million AUD | 0.0% |
| 2018 Q4 | -2.22 Million AUD | 0.0% |
| 2018 FY | -2.21 Million AUD | 61.44% |
| 2017 Q4 | -5.76 Million AUD | 0.0% |
| 2017 FY | -5.75 Million AUD | -80.29% |
| 2016 FY | -3.19 Million AUD | 21.97% |
| 2016 Q4 | -3.2 Million AUD | 0.0% |
| 2015 FY | -4.08 Million AUD | 48.51% |
| 2015 Q4 | -4.08 Million AUD | 0.0% |
| 2014 FY | -7.94 Million AUD | 5.0% |
| 2013 FY | -8.35 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 111.569% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 144.283% |
| SQZ Biotechnologies Company | -36.23 Million USD | 94.968% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 104.261% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 71.075% |
| Mesoblast Limited | 55.85 Million USD | 103.265% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 296.68% |
| Genus plc | 190.6 Million USD | 100.957% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 181.562% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 250.227% |
| Marizyme, Inc. | 18.56 Million USD | 109.821% |
| ContraFect Corporation | -6.02 Million USD | 69.738% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 368.175% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 1454.43% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 257.828% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 181.329% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 133.145% |
| MultiCell Technologies, Inc. | 90.04 USD | 2025412.084% |
| Accustem Sciences Inc. | -733.97 Thousand USD | -148.453% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 114.086% |
| EV Biologics, Inc. | 1.36 Million USD | 233.306% |
| Q BioMed Inc. | 4.06 Million USD | 144.916% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 105.968% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 393.01% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 280.963% |
| Biomind Labs Inc. | 711.4 Thousand USD | 356.338% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 109.8 Million USD | 101.661% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 114.239% |
| Skye Bioscience, Inc. | -5.72 Million USD | 68.127% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 311.986% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 1404.391% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 132.285% |
| IMV Inc. | 7.67 Million USD | 123.774% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 9278.995% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 182.816% |
| GB Sciences, Inc. | 1.74 Million USD | 204.365% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -892.225% |
| HST Global, Inc. | 96.79 Thousand USD | 1984.011% |
| CSL Limited | 10.52 Billion USD | 100.017% |
| Halberd Corporation | 144.72 Thousand USD | 1360.074% |
| Enzolytics Inc. | 981.65 Thousand USD | 285.767% |
| Resverlogix Corp. | 6.45 Million USD | 128.268% |
| Affymax, Inc. | -5.59 Million USD | 67.418% |
| SYBLEU INC | 473.71 Thousand USD | 484.956% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | -170.929% |
| argenx SE | -2.02 Billion USD | 99.91% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 104.199% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 96.121% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 167.326% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 79.371% |
| AVAX Technologies, Inc. | -5.9 Million USD | 69.108% |
| Zenith Capital Corp. | 10.06 Thousand USD | 18219.942% |
| Genscript Biotech Corporation | -1.06 Billion USD | 99.828% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 1009.83% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 176.428% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 1208.505% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 103.012% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 191.207% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -2.57 Million USD | 29.044% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 606.961% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 108.994% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -9855.186% |
| BioStem Technologies, Inc. | 4.47 Million USD | 140.778% |
| ONE Bio Corp. | 9.04 Million USD | 120.172% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 1006.114% |
| Burzynski Research Institute, Inc. | -1310.00 USD | -139105.42% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 984.307% |
| Agentix Corp. | 37.63 Thousand USD | 4945.981% |
| LadRx Corporation | -2.03 Million USD | 10.453% |
| Cell Source, Inc. | 9.23 Million USD | 119.753% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -8835.667% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 387.104% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 387.104% |
| NovAccess Global Inc. | 2.17 Million USD | 183.71% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 125.79% |
| Itoco Inc. | 228.3 Thousand USD | 898.752% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 1440.984% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 136.788% |
| Kadimastem Ltd | -253.1 Thousand USD | -620.496% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 553.8% |
| CytoDyn Inc. | 20.26 Million USD | 109.0% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -281753.323% |
| Mobile Lads Corp. | 484.23 Thousand USD | 476.594% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -19575.487% |
| Qrons Inc. | 351.42 Thousand USD | 618.91% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 123.665% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -630.547% |
| Rebus Holdings, Inc. | 305 Thousand USD | 697.899% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 140.915% |
| International Stem Cell Corporation | 2.59 Million USD | 170.409% |
| Bioxytran, Inc. | 1.89 Million USD | 196.033% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 3021.813% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 183.616% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 153.104% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 121.321% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 336.031% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | -45.887% |
| Neutra Corp. | 52.18 Thousand USD | 3594.34% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 26.734% |
| PureTech Health plc | -167.19 Million USD | 98.909% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -644.602% |
| IXICO plc | -4.44 Million USD | 58.971% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 113.795% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 103.325% |
| CSL Limited | 10.52 Billion USD | 100.017% |
| Cellectis S.A. | -43.81 Million USD | 95.838% |